{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T21:30:29Z","timestamp":1747258229536},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,2,5]],"date-time":"2008-02-05T00:00:00Z","timestamp":1202169600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s12032-008-9046-2","type":"journal-article","created":{"date-parts":[[2008,2,4]],"date-time":"2008-02-04T15:26:54Z","timestamp":1202138814000},"page":"360-364","source":"Crossref","is-referenced-by-count":12,"title":["Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified"],"prefix":"10.1007","volume":"25","author":[{"given":"Agustin","family":"Avil\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natividad","family":"Neri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Cleto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Talavera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Huerta-Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Jes\u00fas","family":"Nambo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,5]]},"reference":[{"key":"9046_CR1","first-page":"2551","volume":"107","author":"MA Rizvi","year":"2005","unstructured":"Rizvi MA, Evers AM, Tallman MS. T-cell non-Hodgkin\u2019s lymphoma. Blood 2005;107:2551\u201364.","journal-title":"Blood"},{"key":"9046_CR2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.2005.05478.x","volume":"129","author":"R Sorren","year":"2005","unstructured":"Sorren R, Schmidt WP, M\u00fcller-Hermelink HK, Schmitz N. The International Prognostic Index determines the outcome of patients with nodal mature-T cell lymphomas. Br J Haematol 2005;129:366\u201372.","journal-title":"Br J Haematol"},{"key":"9046_CR3","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/annonc\/mdh392","volume":"15","author":"KJ Savage","year":"2004","unstructured":"Savage KJ, Chharabhai M, Gascoyne RD, Connors JM. Characteristics of peripheral T-cell lymphomas in a single North-American Institution by the WHO classification. Ann Oncol 2004;15:1467\u201375.","journal-title":"Ann Oncol"},{"key":"9046_CR4","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","volume":"103","author":"A Gallamini","year":"2004","unstructured":"Gallamini A, et\u00a0al. Peripheral T-cell lymphoma unspecified (PTCLu). A new prognostic model from a retrospective multicentric clinical trial. Blood 2004;103:2474\u20139.","journal-title":"Blood"},{"key":"9046_CR5","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2001.19.17.3766","volume":"19","author":"J Rodriguez","year":"2001","unstructured":"Rodriguez J, et\u00a0al. Impact of high-dose chemotherapy on peripheral T-cell lymphomas. J Clin Oncol 2001;19:3766\u201370.","journal-title":"J Clin Oncol"},{"key":"9046_CR6","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/annonc\/mdh471","volume":"15","author":"N Mounier","year":"2004","unstructured":"Mounier N, et\u00a0al. All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation. Ann Oncol 2004;15:1790\u20137.","journal-title":"Ann Oncol"},{"key":"9046_CR7","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/cncr.20999","volume":"103","author":"MP Escalon","year":"2005","unstructured":"Escalon MP, et\u00a0al. Prognostic factors and treatment of patients with T-cell non-Hodgkin\u2019s lymphoma. Cancer 2005;103:2091\u20138.","journal-title":"Cancer"},{"key":"9046_CR8","first-page":"402","volume":"43","author":"RL TenBerg","year":"2003","unstructured":"TenBerg RL, et\u00a0al. ALK-negative anaplastic large-cell lymphoma demonstrate similar poor prognosis to peripheral T-cell lymphoma unspecified. Histopathology 2003;43:402\u20139.","journal-title":"Histopathology"},{"key":"9046_CR9","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1080\/10428190412331272749","volume":"45","author":"M Jagasia","year":"2004","unstructured":"Jagasia M, et\u00a0al. Histologic impacts the outcome of peripheral T-cell lymphoma after high dose chemotherapy and stem cell transplant. Leuk Lymphoma 2004;45:2261\u20137.","journal-title":"Leuk Lymphoma"},{"key":"9046_CR10","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/cncr.20531","volume":"101","author":"F Morabito","year":"2004","unstructured":"Morabito F, et\u00a0al. Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphoma unspecified and 496 diffuse large B-cell lymphoma. Cancer 2004;101:1601\u20138.","journal-title":"Cancer"},{"key":"9046_CR11","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1200\/JCO.1997.15.6.2296","volume":"15","author":"SM Ansell","year":"1997","unstructured":"Ansell SM, et\u00a0al. Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. J Clin Oncol 1997;15:2296\u2013301.","journal-title":"J Clin Oncol"},{"key":"9046_CR12","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/sj.leu.2404306","volume":"20","author":"P Corradini","year":"2006","unstructured":"Corradini P, et\u00a0al. Long-term follow-up of patients with peripheral T-cell lymphoma treated up-front with high dose chemotherapy followed by autologous stem cell transplantation. Leukemia 2006;20:1532\u20138.","journal-title":"Leukemia"},{"key":"9046_CR13","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1054\/bjoc.2001.2130","volume":"85","author":"L Loni","year":"2001","unstructured":"Loni L, Del Tacca M, Naresi R. Pharmacogenetics of anticancer drugs in non-Hodgkin\u2019s lymphoma. Br J Cancer 2001;85:1425\u201331.","journal-title":"Br J Cancer"},{"key":"9046_CR14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/MO:20:1:13","volume":"20","author":"A Avil\u00e9s","year":"2003","unstructured":"Avil\u00e9s A, et\u00a0al. Nasal NK\/T cell lymphoma with disseminated disease treated with aggressive combined therapy. Med Oncol 2003;20:13\u20137.","journal-title":"Med Oncol"},{"key":"9046_CR15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, et\u00a0al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25:579\u201383.","journal-title":"J Clin Oncol"},{"key":"9046_CR16","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1080\/10428190410001667712","volume":"45","author":"A Avil\u00e9s","year":"2004","unstructured":"Avil\u00e9s A, et\u00a0al. Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improve outcome. Leuk Lymphoma 2004;45:1385\u20139.","journal-title":"Leuk Lymphoma"},{"key":"9046_CR17","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1200\/JCO.1991.9.8.1426","volume":"9","author":"LW Kwank","year":"1991","unstructured":"Kwank LW, et\u00a0al. Similar outcome of treatment of B-cell and T-cell diffuse large cell lymphoma. J Clin Oncol 1991;9:1426\u201331.","journal-title":"J Clin Oncol"},{"key":"9046_CR18","first-page":"76","volume":"92","author":"C Gisselbrecht","year":"1998","unstructured":"Gisselbrecht C, et\u00a0al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin\u2019s lymphoma. Blood 1998;92:76\u201382.","journal-title":"Blood"},{"key":"9046_CR19","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1182\/blood.V89.12.4514","volume":"89","author":"A Melnyk","year":"1997","unstructured":"Melnyk A, Rodriguez A, Pugh WC, Cabanillas F. Evaluation of the revised European-American Lymphoma Classification confirm the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin\u2019s lymphoma. Blood 1997;89:4514\u201320.","journal-title":"Blood"},{"key":"9046_CR20","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1182\/blood-2003-10-3389","volume":"103","author":"G Enblad","year":"2004","unstructured":"Enblad G, et\u00a0al. A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphoma. Blood 2004;103:2920\u20134.","journal-title":"Blood"},{"key":"9046_CR21","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/annonc\/mdl466","volume":"18","author":"J Rodriguez","year":"2007","unstructured":"Rodriguez J, et\u00a0al. The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission. Ann Oncol 2007;18:652\u20137.","journal-title":"Ann Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-008-9046-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-008-9046-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-008-9046-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T13:20:54Z","timestamp":1588339254000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-008-9046-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,5]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["9046"],"URL":"https:\/\/doi.org\/10.1007\/s12032-008-9046-2","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,5]]}}}